← Back to all clusters

Cluster 347

6 diseases · 11 shared-gene connections
6 Diseases
5 Unique genes
0.297 Avg. similarity score
Congenital facial anomaly Most-connected disease (5 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
CAD 5 / 6 Carbamoyl phosphate synthetase deficiency, Congenital facial anomaly, Congenital hypoplastic anemia, developmental and epileptic encephalopathy, 50 and 1 more
FIBP 2 / 6 Congenital facial anomaly, Thauvin-robinet-faivre syndrome
UMPS 2 / 6 Congenital hypoplastic anemia, Hypoplastic anemia
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Pyrimidine biosynthesis Reactome 2 / 3 1,601× 4.16e-7 2.28e-5 ✓ sig.
Arginine biosynthesis KEGG 2 / 23 209× 3.50e-5 9.50e-4 ✓ sig.
Alanine, aspartate and glutamate metabolism KEGG 2 / 37 130× 9.18e-5 2.09e-3 ✓ sig.
Pyrimidine metabolism KEGG 2 / 58 82.8× 2.27e-4 4.33e-3 ✓ sig.
Biosynthesis of cofactors KEGG 2 / 154 31.2× 1.59e-3 1.93e-2 ✓ sig.
HuR (ELAVL1) binds and stabilizes mRNA Reactome 1 / 8 300× 3.33e-3 3.31e-2 ✓ sig.
Urea cycle Reactome 1 / 10 240× 4.16e-3 3.87e-2 ✓ sig.
Nitrogen metabolism KEGG 1 / 17 141× 7.06e-3 5.49e-2
Transport of Ribonucleoproteins into the Host Nucleus Reactome 1 / 31 77.5× 1.28e-2 7.92e-2
NEP/NS2 Interacts with the Cellular Export Machinery Reactome 1 / 31 77.5× 1.28e-2 7.92e-2
Regulation of Glucokinase by Glucokinase Regulatory Protein Reactome 1 / 31 77.5× 1.28e-2 7.92e-2
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) Reactome 1 / 31 77.5× 1.28e-2 7.92e-2
Vpr-mediated nuclear import of PICs Reactome 1 / 33 72.8× 1.37e-2 8.23e-2
Transport of the SLBP independent Mature mRNA Reactome 1 / 34 70.6× 1.41e-2 8.38e-2
SUMOylation of SUMOylation proteins Reactome 1 / 34 70.6× 1.41e-2 8.38e-2

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
'de novo' pyrimidine nucleobase biosynthetic process GO:0006207 3 / 6 1,869× 1.84e-10 4.96e-8 ✓ sig.
'de novo' UMP biosynthetic process GO:0044205 2 / 3 2,492× 1.72e-7 1.91e-5 ✓ sig.
citrulline biosynthetic process GO:0019240 2 / 4 1,869× 3.44e-7 3.40e-5 ✓ sig.
UDP biosynthetic process GO:0006225 2 / 5 1,495× 5.73e-7 5.25e-5 ✓ sig.
pyrimidine nucleotide biosynthetic process GO:0006221 2 / 9 831× 2.06e-6 1.47e-4 ✓ sig.
response to amine GO:0014075 2 / 10 747× 2.58e-6 1.76e-4 ✓ sig.
glutamine metabolic process GO:0006541 2 / 15 498× 6.01e-6 3.47e-4 ✓ sig.
response to starvation GO:0042594 2 / 37 202× 3.80e-5 1.46e-3 ✓ sig.
liver development GO:0001889 2 / 87 85.9× 2.12e-4 5.27e-3 ✓ sig.
carbamoyl phosphate biosynthetic process GO:0070409 1 / 1 3,737× 2.68e-4 6.20e-3 ✓ sig.
response to oleic acid GO:0034201 1 / 2 1,869× 5.35e-4 9.98e-3 ✓ sig.
monoatomic anion homeostasis GO:0055081 1 / 2 1,869× 5.35e-4 9.98e-3 ✓ sig.
pyrimidine-containing compound biosynthetic process GO:0072528 1 / 2 1,869× 5.35e-4 9.98e-3 ✓ sig.
cellular response to oleic acid GO:0071400 1 / 3 1,246× 8.03e-4 1.30e-2 ✓ sig.
UMP biosynthetic process GO:0006222 1 / 3 1,246× 8.03e-4 1.30e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Congenital hypoplastic anemia Hypoplastic anemia 0.667 2 8.44e-9 7.20e-8 ✓ sig.
Carbamoyl phosphate synthetase deficiency developmental and epileptic encephalopathy, 50 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Congenital hypoplastic anemia developmental and epileptic encephalopathy, 50 0.333 1 1.30e-4 3.90e-4 ✓ sig.
developmental and epileptic encephalopathy, 50 Hypoplastic anemia 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Congenital facial anomaly Thauvin-robinet-faivre syndrome 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Congenital facial anomaly developmental and epileptic encephalopathy, 50 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Carbamoyl phosphate synthetase deficiency Hypoplastic anemia 0.250 1 2.60e-4 6.40e-4 ✓ sig.
Carbamoyl phosphate synthetase deficiency Congenital hypoplastic anemia 0.250 1 2.60e-4 6.40e-4 ✓ sig.
Congenital facial anomaly Hypoplastic anemia 0.200 1 3.90e-4 8.52e-4 ✓ sig.
Carbamoyl phosphate synthetase deficiency Congenital facial anomaly 0.200 1 3.90e-4 8.52e-4 ✓ sig.
Congenital facial anomaly Congenital hypoplastic anemia 0.200 1 3.90e-4 8.52e-4 ✓ sig.